4baseCare Secures ₹90 Crore Investment to Accelerate International Expansion of Personalized Cancer Care
What is the news?
4baseCare, an Illumina Accelerator-backed oncology startup, has announced a successful funding round of ₹90 Crore. Led by veteran investors Ashish Kacholia and Lashit Sanghvi, the investment marks a significant vote of confidence in the company’s mission to democratize precision oncology. Founder Hitesh Goswami has built a platform that leverages advanced genomics and clinical data to provide personalized treatment recommendations for cancer patients, moving away from the “one size fits all” approach.
Why is it interesting?
The growth of 4baseCare is a defining narrative for the “Global Indian Alpha” initiative. By developing proprietary genomic tests and building a comprehensive clinico-genomic data platform, the founders are addressing a critical gap in the global healthcare ecosystem. The new infusion of capital will be strategically deployed to expand the company’s research and development capabilities and to establish a stronger presence in international corridors, including Southeast Asia and the Middle East, where the demand for specialized cancer care is rising rapidly.
As 4baseCare scales, it continues to reinforce India’s reputation as a global knowledge hub for biotechnology. The success of the founder within the broader “founders community” illustrates the power of combining technical expertise with a vision for global impact. This funding milestone not only secures the company’s growth trajectory but also highlights the vital role that Indian-origin leadership plays in advancing the frontier of global medical innovation.
Read more: Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi